Form 6K Opthea Ltd For: 12 November
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ceryvyn Therapeutics Ltd (CYV)
Ceryvyn Therapeutics Ltd stock price live, this page displays ASX CYV stock exchange data. View the CYV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ceryvyn Therapeutics Ltd real time stock price chart below.
What Is the Ceryvyn Therapeutics Ltd Stock Price Today?
The Ceryvyn Therapeutics Ltd stock price today is 0.01.
What Is the Stock Symbol for Ceryvyn Therapeutics Ltd?
The stock symbol for Ceryvyn Therapeutics Ltd is "CYV."
What Stock Exchange Does Ceryvyn Therapeutics Ltd Trade On?
Ceryvyn Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Ceryvyn Therapeutics Ltd a Good Stock to Buy?
Determining whether Ceryvyn Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYV quote. (ISIN: AU0000478117)
What Is the Ceryvyn Therapeutics Ltd Stock Price Today?
The Ceryvyn Therapeutics Ltd stock price today is 0.01.
What Is the Stock Symbol for Ceryvyn Therapeutics Ltd?
The stock symbol for Ceryvyn Therapeutics Ltd is "CYV."
What Stock Exchange Does Ceryvyn Therapeutics Ltd Trade On?
Ceryvyn Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is Ceryvyn Therapeutics Ltd a Good Stock to Buy?
Determining whether Ceryvyn Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYV quote. (ISIN: AU0000478117)
0.01
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.01
0.01
52 wk Range
0.01
0.03
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.010.01
52 wk Range
0.010.03
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CYV Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Optiva Inc. Announces Results of Annual Meeting
- Investing.com
- Form 6K Opthea Ltd For: 31 October
- Investing.com
- Form 6K Opthea Ltd For: 27 October
- Investing.com
- Form 6K Opthea Ltd For: 12 November
- Investing.com
- Form 6K Opthea Ltd For: 31 October
- Investing.com
- Form 6K Opthea Ltd For: 27 October
- Investing.com
- Form 6K Opthea Ltd For: 19 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Earnings
Latest Release
Mar 01, 2026
EPS / Forecast
0.26 / -7.00
Revenue / Forecast
1K / 50K
Compare CYV to Peers and Sector
Metrics to compare | CYV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCYVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.1x | −8.1x | −0.4x | |
PEG Ratio | 0.00 | −0.06 | 0.00 | |
Price/Book | 0.5x | 2.2x | 2.6x | |
Price / LTM Sales | −884.0x | 20.3x | 3.0x | |
Upside (Analyst Target) | - | 236.8% | 51.9% | |
Fair Value Upside | Unlock | −2.1% | 9.4% | Unlock |
Ceryvyn Therapeutics Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company’s pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Ceryvyn (CYV) Stock Price Today?
The Ceryvyn stock price today is 0.01 AUD.
What Stock Exchange Does Ceryvyn Trade On?
Ceryvyn is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Ceryvyn?
The stock symbol for Ceryvyn is "CYV."
What Is the Ceryvyn Market Cap?
As of today, Ceryvyn market cap is 13.68M AUD.
What Is Ceryvyn's Earnings Per Share (TTM)?
The Ceryvyn EPS (TTM) is 0.23.
From a Technical Analysis Perspective, Is CYV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ceryvyn Stock Split?
Ceryvyn has split 1 times.
How Many Employees Does Ceryvyn Have?
Ceryvyn has 33 employees.
What is the current trading status of Ceryvyn (CYV)?
As of Jul 09, 2026, Ceryvyn (CYV) is trading at a price of 0.01 AUD, with a previous close of 0.01 AUD. The stock has fluctuated within a day range of 0.01 AUD to 0.01 AUD, while its 52-week range spans from 0.01 AUD to 0.03 AUD.
What Is Ceryvyn (CYV) Price Target According to Analysts?
The average 12-month price target for Ceryvyn is 0.10 AUD, with a high estimate of 0.1 AUD and a low estimate of 0.1 AUD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +900.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.